scholarly journals Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass

2000 ◽  
Vol 119 (6) ◽  
pp. 1297-1298 ◽  
Author(s):  
Sebastian Pagni ◽  
Erle H. Austin
Keyword(s):  
Methylene Blue ◽  
Cardiopulmonary Bypass ◽  
Refractory Hypotension

scholarly journals The Use of Methylene Blue during Liver Transplantation for Vasoplegia

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Paul Harding ◽  
Thomas Nicholas ◽  
Cale Kassel
Keyword(s):  
Septic Shock ◽  
Methylene Blue ◽  
Liver Transplantation ◽  
Cardiopulmonary Bypass ◽  
Liver Failure ◽  
Acute Liver Failure ◽  
Treatment Option ◽  
Case Reports ◽  
Refractory Hypotension

The use of methylene blue for vasoplegia in cardiac cases with cardiopulmonary bypass, septic shock, and acute liver failure is well documented. Use of MB for liver transplantation has been largely limited to case reports. We describe three separate liver transplantation patients with significant hypotension following reperfusion. Administration of methylene blue to each patient resulted in a significant decrease in vasopressor medication and two patients weaned completely. We argue that the use of MB should be considered as a treatment option for refractory hypotension.

Methylene blue does not neutralize heparin after cardiopulmonary bypass

1996 ◽  
Vol 10 (4) ◽  
pp. 474-476 ◽  
Author(s):  
Samuel Metz ◽  
Jan C. Horrow ◽  
Inder P. Goel ◽  
M.L.R. Kuretu ◽  
Collette Bellwoar
Keyword(s):  
Methylene Blue ◽  
Cardiopulmonary Bypass
Sign in / Sign up

Export Citation Format

Share Document